Session Details
[JS15★☆]Pioneering Cancer Therapies Through Pharmaceutical Science (the 3rd time) —Toward Generating New Insights—
Sun. Mar 29, 2026 1:10 PM - 3:10 PM JST
Sun. Mar 29, 2026 4:10 AM - 6:10 AM UTC
Sun. Mar 29, 2026 4:10 AM - 6:10 AM UTC
Room 04 (E301)
Organizer: Ryuji Ikeda (Univ. Miyazaki Hosp. Dept. Pharm), Tomohiro Miyake (Dept. Pharm., Ise Red Cross Hosp.), Motohiko Sano (Hoshi Univ.), Yukiyoshi Fujita (Div. Pharm., Gunma Prefectural Cancer Center)
Co-sponsored by:
The Pharmaceutical Society of Japan,
the Japanese Society of Pharmaceutical Health Care and Sciences
The Pharmaceutical Society of Japan,
the Japanese Society of Pharmaceutical Health Care and Sciences
オーガナイザー挨拶
池田 龍二(宮崎大病院薬)
[JS15-1]Converting clinical questions into research questions: From the clinical“Why?”to the research“How?”
○Yoshitaka Saito1 (1. Faculty of Pharmaceutical Sciences, Hokkaido University of Science)
[JS15-2]Innovating preventive strategies in cancer supportive care via data-driven clinical pharmacology: Synergizing big data analysis and basic research
○Mitsuhiro Goda1,2, Keisuke Ishizawa2,3,4 (1. Grad. Sch. Biomed. & Health Sci. Hiroshima Univ., 2. Grad. Sch. Biomed. Sci. Tokushima Univ., 3. Dept. Pharm., Tokushima Univ. Hosp., 4. Clin. Res. Ctr., Tokushima Univ. Hosp.)
[JS15-3]Implementing high-quality clinical research: The impact of evidence generation
○Toshinobu Hayashi1 (1. Fac. Pharm. Sci., Fukuoka Univ.)
[JS15-4]Bridging generated evidence to clinical practice — How to interpret and apply guidelines
○Takeshi Aoyama1 (1. Department of Pharmacy Cancer Institute Hospital Japanese Foundation for Cancer Research)
